DXR
Daxor CorporationNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$54.06M
P/E Ratio
5.65
EPS
$1.64
Beta
0.26
52W High
$14.76
52W Low
$8.45
50-Day MA
$10.17
200-Day MA
$11.89
Dividend Yield
—
Profit Margin
34359.00%
Forward P/E
64.52
PEG Ratio
0.00
About Daxor Corporation
Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 26,690 |
| Gross Profit (TTM) | 26,690 |
| EBITDA | — |
| Operating Margin | -9661.00% |
| Return on Equity | 22.50% |
| Return on Assets | -1.64% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $9.07 |
| Price-to-Book | 1.18 |
| Price-to-Sales (TTM) | 2025.70 |
| EV/Revenue | 5.25 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 329.30% |
| Quarterly Revenue Growth (YoY) | -82.60% |
| Shares Outstanding | $5.84M |
| Float | $2.57M |
| % Insiders | 48.94% |
| % Institutions | 6.99% |
Historical Volatility
HV 10-Day
53.83%
HV 20-Day
51.07%
HV 30-Day
56.37%
HV 60-Day
54.37%
HV Rank
65.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($22.50 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026